Exploring binding stability of hydroxy-3-(4-hydroxyphenyl)-5-(4-nitrophenyl)-5,5a,7,8,9,9a-hexahydrothiazolo[2,3-b] quinazolin-6-one with T790M/L858R EGFR-TKD

References

• Agarwal, S. M., Pal, D., Gupta, M., & Saini, R. (2017). Insight into discovery of next generation reversible T MLR inhibitors targeting EGFR activating and drug resistant T790M mutants. Current Cancer Drug Targets, 17(7), 617–636. https://doi.org/10.2174/1568009617666170330112842
   Google Scholar
• Aier, I., Varadwaj, P. K., Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports, 6(1), 1–10. https://doi.org/10.1038/srep34984.
   PubMedGoogle Scholar
• Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins, 17(4), 412–425. https://doi.org/10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• American Cancer Society. (2022). Risk of dying from cancer continues to drop at an accelerated pace. https://www.cancer.org/latest-news/facts-and-figures-2022.html
   Google Scholar
• Amir, M., Ali, I., & Hassan, M. Z. (2013). Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents. Archives of Pharmacal Research, 36(1), 61–68. https://doi.org/10.1007/s12272-013-0004-y
   PubMed Web of Science ®Google Scholar
• Ammar, Y. A., El-Sharief, A. M. S., Belal, A., Abbas, S. Y., Mohamed, Y. A., Mehany, A. B., & Ragab, A. (2018). Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity. European Journal of Medicinal Chemistry, 156, 918–932. https://doi.org/10.1016/j.ejmech.2018.06.061
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., & Hayward, S. (2000). Collective protein dynamics in relation to function. Current Opinion in Structural Biology, 10(2), 165–169. https://doi.org/10.1016/S0959-440X(00)00061-0
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., Postma, J. V., Van Gunsteren, W. F., DiNola, A. R. H. J., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of chemical physics, 81(8), 3684–3690.
   Google Scholar
• Berendsen, H. J., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Borkotoky, S., & Murali, A. (2018). A computational assessment of pH-dependent differential interaction of T7 lysozyme with T7 RNA polymerase. BMC Structural Biology, 17(1), 7–11. https://doi.org/10.1186/s12900-017-0077-9
   Google Scholar
• Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. https://doi.org/10.1002/jcc.21287
   PubMed Web of Science ®Google Scholar
• Chan, B., Hanan, E., Bowman, K., Bryan, M., Burdick, D., Chan, E., Chen, Y., Clausen, S., Dela Vega, T., Dotson, J., Eigenbrot, C., Elliott, R., Heald, R., Jackson, P., Knight, J., La, H., Lainchbury, M., Malek, S., Purkey, H., … Heffron, T. (2016). Discovery of a noncovalent, mutant-selective epidermal growth factor receptor inhibitor. Journal of Medicinal Chemistry, 59(19), 9080–9093. https://doi.org/10.1021/acs.jmedchem.6b00995
   PubMed Web of Science ®Google Scholar
• Chang, H. X., Chou, T. C., Savaraj, N., Liu, L. F., Yu, C., & Cheng, C. C. (1999). Design of antineoplastic agents based on the “2-phenylnaphthalene-type” structural pattern. 4. Synthesis and biological activity of 2-chloro-3-(substituted phenoxy)-1, 4-naphthoquinones and related 5,8-dihydroxy-1,4-naphthoquinones. Journal of Medicinal Chemistry, 42(3), 405–408. https://doi.org/10.1021/jm9804679
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42713–42717. https://doi.org/10.1038/srep42717
   PubMedGoogle Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• El-Azab, A., Al-Omar, M., Abdel-Aziz, A. A.-M., Abdel-Aziz, N., el-Sayed, M. A.-A., Aleisa, A., Sayed-Ahmed, M., & Abdel-Hamide, S. (2010). Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. European Journal of Medicinal Chemistry, 45(9), 4188–4198. https://doi.org/10.1016/j.ejmech.2010.06.013
   PubMed Web of Science ®Google Scholar
• El-Deeb, I. M., Bayoumi, S. M., El-Sherbeny, M. A., & Alaa, A. M. (2010). Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction. European Journal of Medicinal Chemistry, 45(6), 2516–2530. https://doi.org/10.1016/j.ejmech.2010.02.038
   PubMed Web of Science ®Google Scholar
• El-Sayed, S., Metwally, K., El-Shanawani, A. A., Abdel-Aziz, L. M., Pratsinis, H., & Kletsas, D. (2017). Synthesis and anticancer activity of novel quinazolinone-based rhodanines. Chemistry Central Journal, 11(1), 1–10. https://doi.org/10.1186/s13065-017-0333-x
   PubMedGoogle Scholar
• Goyal, S., Jamal, S., Shanker, A., & Grover, A. (2015). Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationships. BMC Genomics, 16(S5), 1–9. https://doi.org/10.1186/1471-2164-16-S5-S8
   PubMedGoogle Scholar
• Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 17. https://doi.org/10.1186/1758-2946-4-17
   PubMed Web of Science ®Google Scholar
• Heald, R., Bowman, K., Bryan, M., Burdick, D., Chan, B., Chan, E., Chen, Y., Clausen, S., Dominguez-Fernandez, B., Eigenbrot, C., Elliott, R., Hanan, E., Jackson, P., Knight, J., La, H., Lainchbury, M., Malek, S., Mann, S., Merchant, M., … Heffron, T. (2015). Noncovalent mutant selective epidermal growth factor receptor inhibitors: A lead optimization case study. Journal of Medicinal Chemistry, 58(22), 8877–8895. https://doi.org/10.1021/acs.jmedchem.5b01412
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1021/ct5007983
   Web of Science ®Google Scholar
• Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nature Reviews. Cancer, 13(10), 714–726. https://doi.org/10.1038/nrc3599
   PubMed Web of Science ®Google Scholar
• Huang, L., & Fu, L. (2015). Mechanisms of resistance to EGFR tyrosine kinase inhibitors. Acta Pharmaceutica Sinica. B, 5(5), 390–401. https://doi.org/10.1016/j.apsb.2015.07.001
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, A. D. Jr. (2013). CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Hunter, T. (2000). Signaling – 2000 and beyond. Cell, 100(1), 113–127. https://doi.org/10.1016/S0092-8674(00)81688-8
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM . Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., Takemura, M., Yabuuchi, H., Soda, H., & Kohno, S. (2005). Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. Lung Cancer (Amsterdam, Netherlands), 49(3), 337–343. S. https://doi.org/10.1016/j.lungcan.2005.03.035
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Landi, L., & Cappuzzo, F. (2013). HER2 and lung cancer. Expert Review of Anticancer Therapy, 13(10), 1219–1228. https://doi.org/10.1586/14737140.2013.846830
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51(10), 2778–2786. https://doi.org/10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Li, D. D., Wu, T. T., Yu, P., Wang, Z. Z., Xiao, W., Jiang, Y., & Zhao, L. G. (2020). Molecular dynamics analysis of binding sites of epidermal growth factor receptor kinase inhibitors. ACS Omega, 5(26), 16307–16314. https://doi.org/10.1021/acsomega.0c02183
   PubMed Web of Science ®Google Scholar
• Lindahl, E., Hess, B., & Van Der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7(8), 306–317. https://doi.org/10.1007/s008940100045
   Web of Science ®Google Scholar
• Majewski, M., Ruiz-Carmona, S., & Barril, X. (2019). An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Communications Chemistry, 2(1), 1–8. https://doi.org/10.1038/s42004-019-0205-5
   Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Mohanta, P. P., Pati, H. N., & Behera, A. K. (2020). The construction of fluorophoric thiazolo-[2, 3-b] quinazolinone derivatives: A multicomponent domino synthetic approach. RSC Advances, 10(26), 15354–15359. https://doi.org/10.1039/D0RA01066A
   PubMed Web of Science ®Google Scholar
• Molsoft LLC. (2007). 3366, North Torrey Pines Court, Suite 300, La Jolla, CA 92037, USA.
   Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 14–33. https://doi.org/10.1186/1758-2946-3-33
   PubMedGoogle Scholar
• Park, J. H., Liu, Y., Lemmon, M. A., & Radhakrishnan, R. (2012). Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. The Biochemical Journal, 448Pt(3), 417–423. https://doi.org/10.1042/BJ20121513
   PubMed Web of Science ®Google Scholar
• Pawara, R., Ahmad, I., Surana, S., & Patel, H. (2021). Computational identification of 2, 4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation. Silico Pharmacology, 9(1), 1–22. https://doi.org/10.1007/s40203-021-00113-x
   PubMedGoogle Scholar
• Pereira, G. R. C., Da Silva, A. N. R., Do Nascimento, S. S., & De Mesquita, J. F. (2019). In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants. Journal of Cellular Biochemistry, 120(3), 3583–3598. https://doi.org/10.1002/jcb.27636
   PubMed Web of Science ®Google Scholar
• Pericherla, K., Khedar, P., Khungar, B., & Kumar, A. (2013). One-pot sequential C-N coupling and cross dehydrogenative couplings: Synthesis of novel azole fused imidazo[1,2-a]pyridines. Chemical Communications (Cambridge, England), 49(28), 2924–2926. https://doi.org/10.1039/c3cc39206f
   PubMed Web of Science ®Google Scholar
• Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Qureshi, R., Ghosh, A., & Yan, H. (2020). Correlated motions and dynamics in different domains of egfr with l858r and t790m mutations. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 19(1), 383–394. https://doi.org/10.1109/TCBB.2020.2995569
   Web of Science ®Google Scholar
• Sadhasivam, A., Nagarajan, H., & Umashankar, V. (2020). Structure-based drug target prioritisation and rational drug design for targeting Chlamydia trachomatis eye infections. Journal of Biomolecular Structure & Dynamics, 38(11), 3131–3143. https://doi.org/10.1080/07391102.2019.1652691
   PubMed Web of Science ®Google Scholar
• Schlessinger, J., & Ullrich, A. (1992). Growth factor signaling by receptor tyrosine kinases. Neuron, 9(3), 383–391. https://doi.org/10.1016/0896-6273(92)90177-F
   PubMed Web of Science ®Google Scholar
• Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007). Epidermal growth factor receptor mutations in lung cancer. Nature Reviews. Cancer, 7(3), 169–181. https://doi.org/10.1038/nrc2088
   PubMed Web of Science ®Google Scholar
• Sharma, J., Bhardwaj, V. K., Das, P., & Purohit, R. (2021). Identification of naturally originated molecules as γ-aminobutyric acid receptor antagonist. Journal of Biomolecular Structure & Dynamics, 39(3), 911–922. https://doi.org/10.1080/07391102.2020.1720818
   PubMed Web of Science ®Google Scholar
• Shukla, H., Shukla, R., Sonkar, A., Pandey, T., & Tripathi, T. (2017). Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility. Scientific Reports, 7(1), 1–11. https://doi.org/10.1038/s41598-017-01235-z
   PubMedGoogle Scholar
• Shukla, G., Tiwari, A. K., Singh, V. K., Bajpai, A., Chandra, H., & Mishra, A. K. (2008). Effect of a novel series of benzothiazolo-quinazolones on epidermal growth factor receptor (EGFR) and biological evaluations . Chemical Biology & Drug Design, 72(6), 533–539. https://doi.org/10.1111/j.1747-0285.2008.00724.x
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics. CA: A Cancer Journal for Clinicians, 69(1), 7–34. 2019 https://doi.org/10.3322/caac.2155.
   PubMed Web of Science ®Google Scholar
• Singh, B., Bulusu, G., & Mitra, A. (2015). Understanding the thermostability and activity of Bacillus subtilis lipase mutants: Insights from molecular dynamics simulations. The Journal of Physical Chemistry. B, 119(2), 392–409. https://doi.org/10.1021/jp5079554
   PubMed Web of Science ®Google Scholar
• Sonawane, V., Siddique, M. U. M., Jadav, S. S., Sinha, B. N., Jayaprakash, V., & Chaudhuri, B. (2019). Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy. European Journal of Medicinal Chemistry, 165, 115–132. https://doi.org/10.1016/j.ejmech.2019.01.011
   PubMed Web of Science ®Google Scholar
• Thompson, M. A. (2004). Molecular docking using ArgusLab, an efficient shape-based search algorithim and AScore scoring function. In Proceedings of the ACS Meeting, March-172, CINF 42.
   Google Scholar
• Van Aalten, D. M., Conn, D. A., De Groot, B. L., Berendsen, H. J., Findlay, J. B., & Amadei, A. (1997). Protein dynamics derived from clusters of crystal structures. Biophysical Journal, 73(6), 2891–2896. https://doi.org/10.1016/S0006-3495(97)78317-6
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., & MacKerell, A. D. Jr. (2012). Automation of the CHARMM General Force Field (CGenFF) I: Bond perception and atom typing. Journal of Chemical Information and Modeling, 52(12), 3144–3154. https://doi.org/10.1021/ci300363c
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Raman, E. P., & MacKerell, A. D. Jr. (2012). Automation of the CHARMM General Force Field (CGenFF) II: Assignment of bonded parameters and partial atomic charges. Journal of Chemical Information and Modeling, 52(12), 3155–3168. https://doi.org/10.1021/ci3003649
   PubMed Web of Science ®Google Scholar
• Wang, Y., Suh, Y.-A., Fuller, M., Jackson, J., Xiong, S., Terzian, T., Quintás-Cardama, A., Bankson, J., El-Naggar, A., & Lozano, G. (2011). Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense se mutation. The Journal of Clinical Investigation, 121(3), 893–904. https://doi.org/10.1172/JCI44504
   PubMed Web of Science ®Google Scholar
• Wei, M., Chai, W. M., Wang, R., Yang, Q., Deng, Z., & Peng, Y. (2017). Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase. Bioorganic & Medicinal Chemistry, 25(4), 1303–1308. https://doi.org/10.1016/j.bmc.2016.09.042
   PubMed Web of Science ®Google Scholar
• WHO. (2019). Cancer statistics. https://www.who.int/health-topics/cancer#tab=tab_1
   Google Scholar
• WHO. (2021). https://www.who.int/news-room/fact-sheets/detail/cancer
   Google Scholar
• Woo, H. S., Ahn, H. K., Lee, H. Y., Park, I., Kim, Y. S., Hong, J., Sym, S. J., Park, J., Lee, J. H., Shin, D. B., & Cho, E. K. (2014). Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors. Investigational New Drugs, 32(6), 1311–1315. https://doi.org/10.1007/s10637-014-0146-x
   PubMed Web of Science ®Google Scholar
• Xu, W., Jin, Y., Liu, H., Jiang, Y., & Fu, A. H. (2011). Copper-catalyzed domino synthesis of quinazolinones via Ullmann-type coupling and aerobic oxidative C − H amidation. Organic Letters, 13(6), 1274–1277. https://doi.org/10.1021/ol1030266
   PubMed Web of Science ®Google Scholar
• Yadav, D. K., Kumar, S., Choi, E. H., Chaudhary, S., & Kim, M. H. (2020). Computational modeling on aquaporin-3 as skin cancer target: A virtual screening study. Frontiers in Chemistry, 8, 250. https://doi.org/10.3389/fchem.2020.00250
   PubMed Web of Science ®Google Scholar
• Yin, S., Tang, C., Wang, B., Zhang, Y., Zhou, L., Xue, L., & Zhang, C. (2016). Design, synthesis and biological evaluation of novel EGFR/HER2 dual inhibitors bearing a oxazolo[4,5-g]quinazolin-2(1H)-one scaffold. European Journal of Medicinal Chemistry, 120, 26–36. https://doi.org/10.1016/j.ejmech.2016.04.072
   PubMed Web of Science ®Google Scholar
• Yun, C.-H., Mengwasser, K., Toms, A., Woo, M., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. (2008). The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proceedings of the National Academy of Sciences of the United States of America, 105(6), 2070–2075. https://doi.org/10.1073/pnas.0709662105
   PubMed Web of Science ®Google Scholar